Rhenman & Partners Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-241,964
| Closed | -$4.72M | – | 99 |
|
|
2018
Q4 | $4.72M | Sell |
241,964
-338
| -0.1% | -$6.6K | 0.54% | 58 |
|
|
2018
Q3 | $6.45M | Sell |
242,302
-110,000
| -31% | -$2.93M | 0.65% | 58 |
|
|
2018
Q2 | $13.3M | Buy |
352,302
+82,054
| +30% | +$3.1M | 1.36% | 34 |
|
|
2018
Q1 | $8.83M | Buy |
270,248
+59,095
| +28% | +$1.93M | 1.09% | 41 |
|
|
2017
Q4 | $10.3M | Sell |
211,153
-86,247
| -29% | -$4.2M | 1.39% | 26 |
|
|
2017
Q3 | $16.1M | Buy |
297,400
+186,595
| +168% | +$10.1M | 2.05% | 15 |
|
|
2017
Q2 | $6.22M | Sell |
110,805
-10,000
| -8% | -$562K | 0.89% | 43 |
|
|
2017
Q1 | $4.73M | Hold |
120,805
| – | – | 0.75% | 52 |
|
|
2016
Q4 | $2.71M | Hold |
120,805
| – | – | 0.52% | 65 |
|
|
2016
Q3 | $2.74M | Buy |
120,805
+15,805
| +15% | +$359K | 0.44% | 70 |
|
|
2016
Q2 | $2.48M | Hold |
105,000
| – | – | 0.44% | 68 |
|
|
2016
Q1 | $2.14M | Buy |
105,000
+43,000
| +69% | +$877K | 0.43% | 73 |
|
|
2015
Q4 | $3.19M | Sell |
62,000
-9,000
| -13% | -$463K | 0.48% | 66 |
|
|
2015
Q3 | $3.03M | Sell |
71,000
-5,000
| -7% | -$213K | 0.48% | 64 |
|
|
2015
Q2 | $3.46M | Buy |
+76,000
| New | +$3.46M | 0.42% | 75 |
|